Rentokil Initial 购回普通股并拟予注销

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

___________________

FORM 6-K

__________________

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2026

Commission File Number: 001-41524

___________________________________

Rentokil Initial plc

(Registrant’s name)

___________________________________

Compass House

Manor Royal

Crawley

West Sussex RH10 9PY

United Kingdom

(Address of principal executive office)

_____________________________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

03 November 2026

Rentokil Initial plc (the "Company")

Purchase of own shares

The Company announces that, from 27 October 2026 up to and including 30 October 2026, it has purchased the following number of its ordinary shares through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 7 May 2026 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 27 October 2026 as announced on 22 October 2026.

The Company intends to cancel the purchased shares.

Following the cancellation of the repurchased shares, the Company has 2,524,184,660 ordinary shares in issue. The Company does not hold any shares in treasury. This information may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Since 27 October 2026, the Company has purchased 1,855,225 ordinary shares.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), full details of the transactions, in aggregated and detailed form, are available at:

http://www.rns-pdf.londonstockexchange.com/rns/5023B_1-2026-11-2.pdf 

Enquiries:

For further information, please contact:

Investors / Analysts:

Heather Wood, Rentokil Initial plc, +44 7808 098793

Jamie Lewis, Rentokil Initial plc, +44 7341 071944

Media:

Malcolm Padley, Rentokil Initial plc, +44 7788 978 199

About Rentokil Initial plc

Rentokil Initial plc is a global leader in Pest Control and Hygiene & Wellbeing services. It employs c.63,400 people in 90 countries.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.